BF-BBrown-Forman Corporation
Is the price fair?
Undemanding: modest expectations priced in and cheap against its own history.
Priced for ~1% a year FCF growth. Little growth is priced in even as revenue fell 3% a year over three years, potential value, or a value trap.
Cheap vs its own history: P/E 17.0 vs a 28.1 median over 41 quarters (−40% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What BF-B's price assumes
Brown-Forman Corporation trades at 17.0× earnings against 20.2× for the median Consumer Defensive name, cheaper than its own group.
Trailing P/E · Consumer Defensive median 20.2 · cheaper than the typical name in its group
- Price / sales
- 3.40
Price / sales · as of 2026-Q3
- Free cash flow yield
- 7.3%
Free cash flow yield · Consumer Defensive median 6.4%
- Growth the price implies
- +0.65%
Growth the price implies · The price pays for +0.65% free cash flow growth a year for a decade; the business has delivered +45% a year over the last three.
Details›
- Price / bookas of 2026-Q3
- 3.35
- EV / EBITas of 2026-Q3
- 15.5
- EV / salesas of 2026-Q3
- 3.94
- Consumer Defensive median P/E142 names
- 20.2
- Free cash flow, trailing twelve months
- $925M
- Market capitalisation
- $12.7B
- 3-year revenue growth
- −2.8%
- 3-year free cash flow growth
- +45%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $30.53 |
| Its own P/E history, median | $43.63 |
| Its own P/E history, upper quartile | $52.41 |
| 52-week range | $22.60 – $30.33 |
| Today | $26.39 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.